Compounds > hydroxyurea
Page last updated: 2024-10-28

hydroxyurea and ST Elevation Myocardial Infarction

hydroxyurea has been researched along with ST Elevation Myocardial Infarction in 1 studies

ST Elevation Myocardial Infarction: A clinical syndrome defined by MYOCARDIAL ISCHEMIA symptoms; persistent elevation in the ST segments of the ELECTROCARDIOGRAM; and release of BIOMARKERS of myocardial NECROSIS (e.g., elevated TROPONIN levels). ST segment elevation in the ECG is often used in determining the treatment protocol (see also NON-ST ELEVATION MYOCARDIAL INFARCTION).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ielasi, A1
Loffi, M1
Buono, A1
De Blasio, G1
Tespili, M1

Other Studies

1 other study available for hydroxyurea and ST Elevation Myocardial Infarction

ArticleYear
Intracoronary cangrelor administration-assisted primary percutaneous coronary intervention in a patient with essential thrombocythemia and recurrent ST-segment elevation myocardial infarction.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2020, Volume: 21, Issue:10

    Topics: Adenosine Monophosphate; Adult; Angioplasty, Balloon, Coronary; Coronary Thrombosis; Drug-Eluting St

2020